Timothy Richardson, PhD, has 20 years of experience in the fields of medicinal chemistry and drug discovery. He joined the Indiana University School of Medicine in early 2020 as a Senior Research Professor of Medicine in the Division of Clinical Pharmacology.
Before joining IUSM, Dr. Richardson was a Research Fellow at Lilly Research Laboratories, where he made substantial contributions to drug discovery programs that delivered clinical candidates for endocrine, musculoskeletal, and autoimmune diseases. He led technology platform teams focused on Gene Regulation, Epigenetics, and Nuclear Receptors. He also served as a Group Leader in Discovery Chemistry, helping to build a portfolio of small molecule clinical candidates for the Immunology Therapeutic Area. Dr. Richardson finished his career at Lilly as a founding member of the RNA Therapeutics Team facilitating the establishment of internal capabilities as well as an external ecosystem of partnerships, capabilities, and assets for oligonucleotide-based medicines.
Dr. Richardson is beginning his work as a member of the IUSM-Purdue TREAT-AD Center with a focus on establishing the Medicinal Chemistry and Chemical Biology Core in collaboration with the Purdue Institute for Drug Discovery in West Lafayette. Dr. Richardson is looking forward to pursuing research and driving discovery programs in an academic setting in order to advance treatments into the clinic for patients with unmet medical needs.